Zoetis Financial Indicators Patterns

ZTS -- USA Stock  

Earning Report: November 7, 2019  

We strongly advise you to harness Zoetis fundamental analysis to see if markets are presently mispricing the firm. Specifically this interface allows you to validate available financial indicators of Zoetis as well as the relationship between them. We found thirty-eight available indicators for Zoetis which can be compared to its rivals. To make sure the equity is not overpriced, please check out all Zoetis fundamentals including its Gross Profit, Debt to Equity and the relationship between Price to Book and Cash and Equivalents . Given that Zoetis has Price to Earning of 44.73 , we strongly advise you confirm Zoetis prevalent market performance to make sure the company can sustain itself down the road. Use Zoetis to enhance returns of your portfolios. The stock experiences large bullish trend. Check odds of Zoetis to be traded at $140.93 in 30 days.

Chance of Financial Distress

Zoetis has less than 9 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info

Zoetis Company Summary

Zoetis competes with Vertex Pharmaceuticals, Dr Reddys, Perrigo Company, and Regeneron Pharmaceuticals. Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. The company was founded in 1952 and is headquartered in Parsippany, New Jersey. Zoetis operates under Drug Manufacturers - Specialty Generic classification in USA and is traded on BATS Exchange. It employs 10000 people.

Zoetis Return On Asset vs Price to Earnings To Growth

Zoetis is rated fourth in return on asset category among related companies. It is rated fifth in price to earnings to growth category among related companies producing about  0.25  of Price to Earnings To Growth per Return On Asset. The ratio of Return On Asset to Price to Earnings To Growth for Zoetis is roughly  3.93 

Zoetis Systematic Risk

The output start index for this execution was six with a total number of output elements of fifty-five. The Beta measures systematic risk based on how returns on Zoetis correlated with the market. If Beta is less than 0 Zoetis generally moves in the opposite direction as compared to the market. If Zoetis Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Zoetis is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Zoetis is generally in the same direction as the market. If Beta > 1 Zoetis moves generally in the same direction as, but more than the movement of the benchmark. View also all equity analysis or get more info about beta statistic functions indicator.

Zoetis Thematic Clasifications

Obamacare Repeal Idea
Obamacare RepealView

Zoetis October 22, 2019 Opportunity Range

See also Your Current Watchlist. Please also try Aroon Oscillator module to analyze current equity momentum using aroon oscillator and other momentum ratios.
Search macroaxis.com